NCT01637233View on ClinicalTrials.gov

MARCH Central Nervous System Substudy

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
HIV-1 Infection
Interventions
DRUG

Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors

NRTI+PI

DRUG

Arm 2 Maraviroc and Protease Inhibitors

maraviroc + PI

DRUG

Arm 3 Maraviroc and Nucleotide Analogue Reverse Transcriptase Inhibitors

maraviroc + NRTI

Trial Locations (6)

10330

Chulalongkorn University Hospital, Bangkok

C1405CKC

Fundación IDEAA, Buenos Aires

C1221ADC

Hospital Ramos Mejía, Buenos Aires

Unknown

CAICI, Rosario

BN21ES,

Brighton & Sussex University NHS Trust, Brighton

W2

Imperial Healthcare, St. Mary's Hospital, London

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
lead

Kirby Institute

OTHER_GOV

NCT01637233 - MARCH Central Nervous System Substudy | Biotech Hunter | Biotech Hunter